Is Teleflex, Inc. overvalued or undervalued?

As of 25 April 2025, the valuation grade for Teleflex, Inc. has moved from fair to very expensive. The company is currently considered overvalued. Key ratios include a P/E ratio of 13, an EV to EBITDA of 8.74, and a PEG ratio of 0.39, which indicates a significant disparity compared to its peers. For instance, Insulet Corp. has a P/E of 49.67 and an EV to EBITDA of 50.28, while Hologic, Inc. shows a P/E of 21.10 and an EV to EBITDA of 14.37, highlighting that Teleflex's valuation is not justified relative to its competitors.
In addition, the company's recent stock performance has been notably poor, with a year-to-date return of -33.67% compared to a positive return of 2.44% for the S&P 500. This underperformance, combined with the high valuation metrics, reinforces the conclusion that Teleflex, Inc. is overvalued in the current market environment.